Navigation Links
Ambiguous results in screening for celiac disease among young people
Date:11/15/2013

Most children who undergo screening to detect gluten intolerance, celiac disease, can handle it well. However, many people feel that the discovery of the disease and the treatment they receive does not provide a better quality of life. Katrina Nordyke will address this topic as she defends her PhD thesis at Ume University on November 15.

Celiac disease is a chronic disease attributable to genetic susceptibility which causes damage to the small intestine by the intake of gluten in the diet. It is estimated that between 1 and 3 percent of the population have the disease, but the number of unreported cases is high and most sufferers go undiagnosed. Sweden has higher rates of coeliac disease than the rest of the western world.

The benefits of screening for celiac disease in the general population is controversial and the consequences of being diagnosed when screening has been unclear. Sweden has had an epidemic of celiac disease. Therefore, researchers at Ume University conducted the population-based research project ETICS, Exploring the Iceberg of Celiacs in Sweden, to investigate issues arising with celiac disease and screening for the disease. All sixth graders in five regions in Sweden were invited to participate in the study during 2005/2006 and 2009/2010.

In her thesis, Katrina Nordyke examines the experiences and results of screening to detect celiac disease in these children. She notes that the results are ambiguous.

"Most kids can handle the concerns of the screening examination and thoughts about the disease may present. However, there was no consensus that the detection of disease and treatment results in an increased health-related quality of life.", says Katrina Nordyke.

The children involved in ETICS wrote short stories where they described their screening experience before they received their screening results. The stories show that some children experienced the fear and anxiety, but as a whole they managed the screening well. The kids also filled out surveys about their health-related quality of life at the time of the screening and one year after diagnosis. Finally, those who received a celiac diagnosis from the screening wrote new stories one and five years after diagnosis.

According to Katrina Nordyke, the stories show that the threat from complications caused by the disease affected how young people experienced the diagnosis, how they coped with the gluten-free diet and what they thought of screening for celiac disease.

"Five years after diagnosis of celiac disease, the majority of young people have learned to live with the disease, and acquired habits and strategies to cope with living with gluten-free diet. But at the same time some of these young people still doubt the benefits of having been diagnosed with celiac disease through the screening", says Katrina Nordyke.

Katrina Nordyke comes from the United States where she worked as a nurse. Today, she lives in Ume, where she received a Masters Degree in Public Health and is a PhD student at the Department of Public Health and Clinical Medicine, Ume University.


'/>"/>

Contact: Katrina Nordyke
katrina.nordyke@epiph.umu.se
46-709-622-688
Umea University
Source:Eurekalert

Related medicine news :

1. Study finds that Americans want doctors guidance on genetic test results
2. SweetCheeks Products Goes ‘Thigh Tech’ with First Anti-Cellulite Mat with Immediate Results for at Home Use
3. Congenital blindness results in lower thermal pain thresholds
4. Experimental drug shows encouraging results in treating most common form of lung cancer
5. Results of the GIANT trial reported at TCT 2013
6. Targeted Medical Pharma Reports Initial Results From a Clinical Observation of Medical Foods for Autistic Spectrum Disorder Symptoms
7. Results of the OPTIMIZE trial presented at TCT 2013
8. Results of the ARCTIC-INTERRUPTION trial presented at TCT 2013
9. Results of DUTCH PEERS (TWENTE II) trial reported at TCT 2013
10. HIPAA Crackdown Results in Expansion of Secure Texting Solution for Physicians
11. Results of the COREVALVE EXTREME RISK trial presented at TCT 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... the organization behind the New England Journal of Medicine and NEJM Journal Watch, ... Knowledge+ Pediatrics Board Review was created by a panel of pediatricians from leading ...
(Date:3/27/2017)... Lake Orion, Michigan (PRWEB) , ... March 27, ... ... loss results. The comprehensive weight management program at Women’s Excellence will help ... an initial evaluation and physical exam. The specialists at Women's Excellence will ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... settlement agreement to resolve the pending litigation between itself and 1800 Vending DBA ... of Utah). , “I am thrilled to announce that we have now reached ...
(Date:3/26/2017)... Columbus, Ohio (PRWEB) , ... March 26, 2017 ... ... 100 doctors worldwide to receive the RealSelf 100 Award, a prestigious award honoring ... elective cosmetic procedures and to find and connect with doctors and clinics. , ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017 The ... in the wealthiest countries have access to the latest ... countries like the US, many patients have inadequate or ... debts or skip therapy altogether. Access to modern cancer ... less affluent countries. The mission statements ...
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Inc. , a privately held, clinical-stage biopharmaceutical company developing immunogene therapeutics, ... Operating Officer, is scheduled to present a corporate overview at two ... BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 PM ... ... Leaders in Biotech Industry – Friday, April 7, 2017 at 11:20 ...
Breaking Medicine Technology: